(Date:11/7/2009)...-USNewswire/ -- The American Medical Association (...r Citizenship and Community Service to Manus C. Kr...e award recognizes physicians who have gone above ... an outstanding public service contribution to the...oday during the opening session of the 2009 Interi...
(Date:11/7/2009)...David A. Cook (GA), Louis J. Goodman (TX), Palmer ... CHICAGO, Nov. 7 The Am...ive medical society executive leaders with achieve...als and ideals of the medical profession. The awar...making meeting in Houston. ,, (Logo: http://...
(Date:11/7/2009)...USNewswire/ -- Members of the AMA are trying a las...on rescinding the AMA,s support of HR 3962. ,,...nsible to their PATIENTS, not the leadership of th...r the Association of American Physicians and Surge...medical groups. ,, "If the AMA leadership igno...
(Date:11/7/2009)... have a responsibility to vigorously oppose aborti... ,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire...eleased the following statement on the news that C...elosi,s Affordable Health Care for America Act (H....tus quo for abortion is voted upon. ,, "Our Ca...
(Date:11/7/2009)...re-USNewswire/ -- Speaker Nancy Pelosi and Democra...on following a Democratic Whip meeting with Presid...e Speaker,s opening remarks: ,, "Thank you ver...r us to receive the President of the United States...ur vote and making progress for the American peopl...
Breaking Medicine News(10 mins):Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2... Upon the completion of a highly successful CI...ia proudly announces their next business technolog...echnology executives in healthcare. CDM Media has ...(PRWEB) October 11, 2008 -- Upon the completion of...
...alif., Oct. 10 A senior citizen,soared over the 1...all,plane. The high-flying adventure was taken by ...e from a last-wish program through Silverado Hospi...y realize a special activity at the end of their l...
...iation could lessen long-term side effects, study ...) -- Using chemotherapy alone, and delaying or avo...eating children with inoperable or progressive low... performed, the survival rate for patients is 95 p...
... of Health (NIH) scientists have identified a prot... white blood cells, T and B cells, enabling them t...g long-lasting immunity after an infection. Their...tions with a common virus that otherwise is rarely...
.... 10 Accuray,Incorporated (Nasdaq: ARAY ), a glo...unced that it will report results for its first qu... on Wednesday, October 29, 2008 after,the market c...nd,chief executive officer and Holly Grey, senior ...
...alists Will Give Accredited Course for,Non-Dermato..., To be held November 1, 2008 at the Royal Sonest.... 9 The Melanoma,Foundation of New England and th...ologists on the detection and management,of melano...
Other Medicine News:Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2(Date:11/6/2009)...swire/ -- America,s Specialty Medicines Companies ...d smaller innovator pharmaceutical companies, toda...ble Health Care for America Act," introduced by Ho...ies fear that the cumulative effect of a host of p...o bring new medicines to market. ,, From requ...
(Date:11/6/2009)...rstCall/ -- Boston Scientific Corporation (NYSE: ...ment in principle with the U.S. Department of Just...its Guidant subsidiary in 2005. The alleged condu...ntific,s 2006 acquisition of Guidant. ,, Boston...ion by the U.S. Attorney,s Office in Minneapolis i...
(Date:11/6/2009)...all/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), ... of small-molecule therapeutics for the treatment ...HIV), today reported recent accomplishments and fi...ths ended September 30, 2009. ,, (Logo: http... ) ,, "Since our last quarterly update, we have...
Breaking Medicine Technology:Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 1Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 2Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 3Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2Keep Safety in Mind While Cooling Off in the Water 48824 1Keep Safety in Mind While Cooling Off in the Water 48824 2...AUGA, ON, July 09, 2007 /PRNewswire-FirstCall/ - Y...tifies, develops,and commercializes differentiated...that a study presented by investigators from Kinki...y at the 11th,meeting of The Japanese Association ...y 5-6, 2007 demonstrated the increased,radiosensit...
...ER, Massachusetts, July 08, 2007 /PRNewswire/ -- ,...rgently,Implement Hospital-Wide Strategies to Opti... Risk for VTE and Provide Appropriate,prophylaxis ... is high among hospital,patients and most of these...prophylaxis according to data from the internation...
Other Medicine Technology:YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 2International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 3International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis 4...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: